BCL2 and breast carcinoma: Therefore, recent studies verified that the co-delivery of IL17RB siRNA and DOX by nanoparticles can be considered as an effective system for the treatment of breast cancer resulting in a significant silencing of NF-κB and Bcl-2 relative gene expression, apoptosis induction, and migration inhibition in breast cancer cells (76).